Viewing Study NCT00419250


Ignite Creation Date: 2025-12-24 @ 5:19 PM
Ignite Modification Date: 2025-12-28 @ 8:49 PM
Study NCT ID: NCT00419250
Status: COMPLETED
Last Update Posted: 2019-11-08
First Post: 2007-01-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia
Sponsor: Celgene
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module